Business Wire

CARGILL

13.3.2024 09:01:38 CET | Business Wire | Press release

Share
Cargill Shares Outcome of the World’s First Wind-Powered Ocean Vessel’s Maiden Voyage

Cargill today revealed exciting results of the six-month test period of the Pyxis Ocean, underscoring the potential for the wind assisted propulsion technology in moving the shipping industry toward renewable energy use. The MC Shipping Kamsarmax vessel retrofitted with two WindWings® -large solid wind sails developed by BAR Technologies - - has achieved performance consistent with what was predicted which is equivalent to an average of 3 tonnes of fuel per day.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313673847/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Pyxis Ocean sailing through the English Channel from Spain to Amsterdam, March 2024 (Photo: Business Wire)

“We are encouraged by the results and have learned a great deal about implementing wind assisted propulsion on dry bulk vessels,” said Jan Dieleman, president of Cargill’s Ocean Transportation business. “We could never have done this alone – BAR Technologies and MC Shipping and have been fantastic partners in making the Pyxis Ocean a reality as well as the captain and crew. We are on the leading edge of change in the shipping industry and believe technologies that harness the wind could be an important, cost-effective way to achieve our decarbonization goals in the short, medium and long-term.”

The Pyxis Ocean hit open waters in August 2023 and during the first six months of testing it has sailed the Indian Ocean, Pacific Ocean, North and South Atlantic, and passed Cape Horn and the Cape of Good Hope. The ship was retrofitted with two WindWings®, which measure 37.5 meters in height and resemble large airplane wings. The wings are installed vertically to catch the wind and propel the ship forward, allowing the ship’s engine to be turned down so that the ship can travel at the same speed as a conventional ship using less fuel. The wings are controlled by a touch panel on the bridge. A simple traffic light system tells the crew when to raise or lower the sails. Once raised, the operation is fully automated: sensors onboard constantly measure the wind, and the sails self-adjust to the optimal configuration.

Wind assisted propulsion has potential to be a cost-efficient way of supporting the International Maritime Organization's (IMO) new greenhouse gas strategy. One of the IMOs 2030 targets is to have 5 percent, striving for 10 percent, of energy coming from very low carbon sources by 2030: wind assisted propulsion could be an important way of achieving this.

The early voyages have provided insight on more than just the application of the sails on a vessel, it has also highlighted broader logistical challenges in the global maritime system. Given that every port, terminal, and berth is different, their involvement is critical towards integrating Wind Assisted Propulsion (WAP) technology into the global maritime system on a wider scale.

John Cooper, BAR Technologies CEO added, “The results of the Pyxis Ocean’s first voyage with WindWings® installed clearly demonstrate that wind assisted propulsion can secure significant fuel savings and emissions reduction. For example, in near optimum sailing conditions, during an open sea voyage, the Pyxis Ocean achieved fuel savings of 11 tonnes per day. And while the Pyxis Ocean has two WindWings®, we anticipate the majority of Kamsarmax vessels will carry three wings, further increasing the fuel savings and emissions reductions by a factor of 1.5. With Cargill we are now able to validate our performance predictions and modelling in real-world conditions, it’s an exciting time as we begin to roll out WindWings® production globally.”

“Cargill is creating ways for all WAP vessels - not just the Pyxis Ocean - to operate on global trade routes,” said Dieleman. “So far, we’ve engaged with more than 250 ports to find ways of enabling vessel with large scale WAP to berth. This complexity is where Cargill truly excels, and how we can leverage our unique role in the maritime industry. We are not afraid to be a development partner and invest, share risks with partners, and to make a difference in transforming the industry.”

Cargill will continue the testing and experimenting of operational, technical and commercial aspects of the Pyxis Ocean to incorporate the maximum amount of learning into potential design of future installations before scaling up.

Notes to editors:

[1]

  • BAR Technolgies and Cargill estimate an annual average savings of 3 tonnes of fuel reductions per day (this equates to 11,2/t/day CO2e well-to-wake emissions reductions. This equates to roughly 14 percent savings on Pyxis Ocean.
  • Average performance measured so far is within 10% of predictions made using computational fluid dynamics (CFD) simulations by BAR Technologies to estimate how well wind assisted propulsion would work on Cargill routes.
  • During optimal sailing conditions, the Pyxis Ocean achieved savings of more than 11t/day in fuel consumption, which translates to 41t/day less CO2e emitted well-to-wake, or a 37% emissions savings.
  • The 11.2t/day CO2e average above works out to be about 2650CO2e/yr (11.2t x 237 average sailing days per year = 2650t well-to-wake). This would be the equivalent of removing 480 cars off the road. (Reference: Greenhouse Gas Emissions from a Typical Passenger Vehicle | US EPA)
  • Cargill and MC Shipping have engaged DNV as an independent third party to review and verify the fuel savings calculations.

About WindWings

  • Cargill was the first to install “WindWings,” large solid wing sails with a potential to deliver double-digit percentage reductions in emissions.
  • Working with partner BAR Technologies, Cargill installed WindWings on a Kamsarmax vessel, Pyxis Ocean, that we are chartering from MC Shipping.
  • Installation was done at COSCO, in Shanghai, China in 2023.
  • Pyxis Ocean is now the most energy efficient Kamsarmax in Cargill’s fleet of chartered vessels
  • The Pyxis Ocean will be used to inform the potential scale-up across the fleet and industry. Cargill plans to continuously learn how to further improve design, operation, and performance.
  • The WindWing project is part of a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 955286

About Cargill Ocean Transportation

Cargill Ocean Transportation is a leading freight-trading organization that charters around 650 vessels worldwide at any one time. Founded in 1956 in Geneva, we benefit from the rich heritage and expert capabilities of Cargill’s global operations in food, agriculture and commodities trading. Our customers, including other companies as well as Cargill’s own internal businesses, are at the center of everything we do. We provide services that combine the latest digital technology with green solutions to make shipping safer and more sustainable.

About Cargill

Cargill is committed to providing food, ingredients, agricultural solutions, and industrial products to nourish the world in a safe, responsible, and sustainable way. Sitting at the heart of the supply chain, we partner with farmers and customers to source, make and deliver products that are vital for living.

Our 160,000 team members innovate with purpose, providing customers with life’s essentials so businesses can grow, communities prosper, and consumers live well. With 159 years of experience as a family company, we look ahead while remaining true to our values. We put people first. We reach higher. We do the right thing—today and for generations to come. For more information, visit Cargill.com and our News Center

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240313673847/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release

Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye